Research at the School

The aim of the School is to conduct internationally excellent peer reviewed basic, clinical and translational research relating to a diverse range of medical conditions and treatments.

The Addenbrooke’s campus also houses the MRC Laboratory of Molecular Biology, the MRC Dunn Nutrition Unit, the CRUK-Cancer Research Institute, which has close links with the Department of Oncology, and the Addenbrooke’s Clinical Research Centre which includes the Wellcome Trust Clinical Research Facility. The Clinical School currently comprises over 600 academic and contract research staff including 81 Professors and Readers, 33 Senior/University Lecturers and 73 Senior Research Fellows (funded by MRC, Wellcome Trust, CRUK and other major medical charities). More than 500 NHS staff, both clinical Consultants and those in Professions allied to Medicine, make a major contribution to the teaching and research base of the Clinical School.

There are many research themes which are jointly covered by the School of Clinical Medicine and the School of Biological Sciences. For more information please visit the Life Sciences Research in Cambridge website

Read more

Information Governance

The information governance policy applies to all areas of the Clinical School, however, the implementation of the policy may vary slightly depending on the systems already in place.

Read more

Research Governance

Information on who to contact and how to start a research project

Read more

Featured Research News

Dementia occurrence stabilising in Western Europe

August 28, 2015

Research published in The Lancet Neurology by Miss Yu-Tzu Wu and Professor Carol Brayne (Institute for Public Health), and colleagues,…

Evaluation of a complex intervention to support people with breathlessness leads to international impact

August 28, 2015

A research programme (published in BMC Medicine) evaluating a pioneering breathlessness service for patients with advanced disease and their families by Dr…

MRC, GSK and five leading UK universities collaborate to crack difficult disease areas

August 25, 2015

Cambridge has been part of a successful £16 million bid to work with the MRC, GSK and four other UK…

Hope for first treatment targeting cause of debilitating heart and lung disease

August 14, 2015

Pulmonary arterial hypertension (PAH), or severe high blood pressure in the lung arteries, is a rare disease affecting some 6000…

Regular consumption of sugary drinks associated with type 2 diabetes

August 14, 2015

Dr Fumiaki Imamura and colleagues (MRC Epidemiology) have found that, regardless of obesity status, habitual consumption of sugar-sweetened drinks is…

View all Research News